New Research: Treating Prostate Cancer with Stereotactic Body Radiation Therapy

In the last decade, stereotactic body radiation therapy (SBRT) has become an increasingly accepted treatment approach for prostate cancer thanks to clinical studies and research completed by some of the world’s top cancer experts. Below are three recently published studies that support the use of SBRT for prostate cancer. The advanced approach delivers precisely focused radiation to a patient’s prostate cancer in five or fewer outpatient treatments. The pinpoint precision of radiation delivery minimizes damage to surrounding healthy tissue.

• A study recently presented at the 2014 Genitourinary Cancers Symposium followed the treatment-related bother of 228 patients with localized prostate cancer for two years following CyberKnife SBRT. Bother is a term used to refer to various side effects a man may experience as a result of treatment. The study titled “œBother Following Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer“ concluded that SBRT for clinically localized prostate cancer was well tolerated in relation to sexual, urinary and bowel bother.

• Georgetown University published the results of their study titled, “Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer” in the Radiation Oncology Journal. The team reported that SBRT for clinically localized prostate cancer was well tolerated.

• A team of researchers in New York released the results of a study of more than 300 prostate cancer patients treated with CyberKnife SBRT. The study titled, “Stereotactic Body Radiotherapy for Localized Prostate Cancer: Disease Control and Quality of Life at 6 Years,“ detailed that no patients experienced advanced complications from treatment and the treatment option has distinct advantages over other methods such as high dose rate brachytherapy. Led by Dr. Alan Katz, the study is one of the largest of its kind.

These clinical studies are among the research that has prompted insurance providers and cancer organizations across the country to announce support and coverage of SBRT as an appropriate treatment option for prostate cancer. If you’™re interested in learning more about how our center treats prostate cancer with SBRT, click here.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.